Author:
Jeong Sangmin,Kim Soohyun
Reference53 articles.
1. Alsaleh, G., et al. (2010). Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Research & Therapy, 12(4), R135.
2. Andoh, A., et al. (2008). Mucosal cytokine network in inflammatory bowel disease. World Journal of Gastroenterology, 14(33), 5154–5161.
3. Bae, S., et al. (2012). Characterizing antiviral mechanism of interleukin-32 and a circulating soluble isoform in viral infection. Cytokine, 58(1), 79–86.
4. Bai, X., et al. (2010). IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages. Journal of Immunology, 184(7), 3830–3840.
5. Cagnard, N., et al. (2005). Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes. European Cytokine Network, 16(4), 289–292.